Trial Profile
A randomised, active controlled, open-label, 2-way cross-over, multicentre study to investigate the palatability, acceptability, pharmacokinetics, safety and tolerability, and treatment compliance of multidoses of ADV6770 as monotherapy or in combination, in children with childhood absence epilepsy.
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 04 Oct 2017
Price :
$35
*
At a glance
- Drugs Ethosuximide (Primary) ; Ethosuximide
- Indications Absence epilepsy
- Focus Therapeutic Use
- Acronyms KIEKIDS A11CS
- Sponsors Advicenne
- 04 Oct 2017 New trial record